Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Flag Therapeutics Inc.
DescriptionSmall molecule receptor tyrosine kinase (RTK) inhibitor
Molecular Target Receptor tyrosine kinase (RTK)
Mechanism of ActionTubulin inhibitor; Receptor tyrosine kinase (RTK) modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat glioma
Regulatory Designation U.S. - Orphan Drug (Treat glioma);
EU - Orphan Drug (Treat glioma)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today